p-Phenylenediamine | CAS:106-50-3

We serve p-Phenylenediamine CAS:106-50-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
p-Phenylenediamine

Chemical Name:1,4-phenylenediamine
CAS.NO:106-50-3
Synonyms:p-Phenylenediamine
benzene-1,4-diamine
1,4-Diaminobenzene
1,4-Benzenediamine;
Molecular Formula:C6H8N2
Molecular Weight:108.14100
 
Physical and Chemical Properties:
Density:1.15;
Melting point:139oC;
Boiling point:267oC;
Flash point:156oC;
Index of Refraction:1.66;
 
Specification:
Appearance:White flake crystal
Purity(HPLC):≥99.0%
P-Chloro Aniline:≤300ppm
O-Phenylene Diamine:≤300ppm
Fe content:≤5ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hair dyes intermediate



Contact us for information like 1,4-phenylenediamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,4-Benzenediamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,p-Phenylenediamine Use and application,1,4-Diaminobenzene technical grade,usp/ep/jp grade.


Related News: When using the raw materials, as an API manufacturer we produce API in the large reactor in our plant.2,2,3-trifluoro-3-(trifluoromethyl)oxirane manufacturer The Transport Security Administration (TSA) will issue a new security directive to airlines from Sunday, according to a person briefed on the restrictions.4-Bromo-2-Cyanopyridine supplier Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.2,3-Diethyl-5-methylpyrazine vendor Here’s what we can tell you so far:In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .